Evidence map›Paper›PMID 41340563›Full record

ArticleGut microbes2025

The ubiquitin system targets translocated EspH to proteasomal degradation.

Ipsita Nandi, Efrat Zlotkin-Rivkin, Hanan Schoffman, Benjamin Aroeti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ipsita NandiDepartment of Biological Chemistry; The Alexander Silberman Institute of Life Sciences; The Hebrew University of Jerusalem, The Edmond J. Safra Campus - Givat Ram, Jerusalem, Israel.ORCID 0000-0002-4502-2559
Efrat Zlotkin-RivkinDepartment of Biological Chemistry; The Alexander Silberman Institute of Life Sciences; The Hebrew University of Jerusalem, The Edmond J. Safra Campus - Givat Ram, Jerusalem, Israel.ORCID 0000-0002-1396-3573
Hanan SchoffmanProteomics and Mass Spectrometry Unit, The Alexander Silberman Institute of Life Sciences; The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0002-9604-9444
Benjamin AroetiDepartment of Biological Chemistry; The Alexander Silberman Institute of Life Sciences; The Hebrew University of Jerusalem, The Edmond J. Safra Campus - Givat Ram, Jerusalem, Israel.ORCID 0000-0003-2023-7913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EspH is an effector protein secreted by the type III secretion system of various pathogenic

Indexed as

Enteropathogenic Escherichia coliEscherichia coli ProteinsProteasome Endopeptidase ComplexUbiquitinHeLa CellsHumansProtein TransportProteolysisType III Secretion SystemsUbiquitinationEscherichia coli ProteinsProteasome Endopeptidase ComplexType III Secretion SystemsUbiquitineffector polyubiquitylationeffector post-translational modificationsEnteropathogenic E. coli (EPEC)EspHhost-pathogen interactionsmass spectrometryproteasomal degradationtype III secreted effectors

Identifiers

PMID41340563
PMCPMC12688225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.